| LINE ITEM (USD / %) | FY 2025
FILED 2026-01-03 | FY 2024
FILED 2024-12-28 | FY 2023
FILED 2023-12-30 |
|---|---|---|---|
| Revenue (Total Sales) | $3.15B | $2.61B | $2.61B |
| YoY Revenue Growth % | +20.9% | 0.0% | — |
| Gross Profit | $1.42B | $1.16B | — |
| Gross Margin % | 45.2% | 44.5% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $336.8M | $342.3M | $319.3M |
| Operating Margin % | 10.7% | 13.1% | 12.2% |
| Net Income (GAAP) | $227.5M | $245.8M | $231.0M |
| EBITDA (Normalized) | $353.6M | $357.3M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $455.8M | $368.2M | $356.5M |
| Capital Expenditures (CapEx) | $21.0M | $18.8M | — |
| Free Cash Flow (FCF) | $434.8M | $349.4M | $356.5M |
| FCF Margin % | 13.8% | 13.4% | 13.7% |
| Return on Invested Capital (ROIC %) | 16.4% | 33.5% | — |
| Cash & Short-Term Equivalents | $77.2M | $334.1M | — |
| Total Debt (Short + Long Term) | $1.13B | $740.3M | — |
| Total Stockholders' Equity | $564.9M | $400.1M | — |